“Deucravacitinib in Plaque Psoriasis: Maintenance of Response Over 3 Years in the Phase 3 POETYK PSO-1 and PSO-2 Trials”. SKIN The Journal of Cutaneous Medicine 7, no. 6 (November 13, 2023): s241. Accessed November 3, 2025. https://skin.dermsquared.com/skin/article/view/2360.